Teresita Bellido
Concepts (480)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Osteocytes | 62 | 2023 | 206 | 12.840 |
Why?
| Bone and Bones | 44 | 2023 | 468 | 7.500 |
Why?
| Osteoblasts | 54 | 2024 | 449 | 5.660 |
Why?
| Osteogenesis | 32 | 2023 | 351 | 4.850 |
Why?
| Bone Resorption | 27 | 2023 | 304 | 4.760 |
Why?
| Parathyroid Hormone | 16 | 2024 | 147 | 4.310 |
Why?
| Signal Transduction | 39 | 2022 | 1617 | 4.300 |
Why?
| Bone Remodeling | 22 | 2024 | 149 | 4.210 |
Why?
| Osteoclasts | 35 | 2024 | 425 | 4.080 |
Why?
| Apoptosis | 35 | 2017 | 1100 | 3.520 |
Why?
| Glucocorticoids | 12 | 2019 | 219 | 3.090 |
Why?
| Receptor, Parathyroid Hormone, Type 1 | 9 | 2022 | 23 | 2.920 |
Why?
| Mice | 92 | 2024 | 5720 | 2.610 |
Why?
| Animals | 120 | 2024 | 13150 | 2.550 |
Why?
| Osteoporosis | 11 | 2024 | 146 | 2.410 |
Why?
| Adaptor Proteins, Signal Transducing | 21 | 2024 | 193 | 2.400 |
Why?
| Diphosphonates | 10 | 2024 | 90 | 2.320 |
Why?
| Receptors, Notch | 5 | 2022 | 27 | 2.190 |
Why?
| Connexin 43 | 14 | 2017 | 25 | 2.170 |
Why?
| Bone Morphogenetic Proteins | 10 | 2020 | 56 | 2.070 |
Why?
| RANK Ligand | 10 | 2018 | 179 | 1.990 |
Why?
| Glycoproteins | 15 | 2019 | 115 | 1.940 |
Why?
| Mechanotransduction, Cellular | 10 | 2016 | 36 | 1.860 |
Why?
| Wnt Signaling Pathway | 10 | 2022 | 92 | 1.840 |
Why?
| Antioxidants | 4 | 2020 | 248 | 1.640 |
Why?
| beta Catenin | 8 | 2022 | 102 | 1.530 |
Why?
| Bone Density Conservation Agents | 7 | 2024 | 77 | 1.460 |
Why?
| Bone Density | 23 | 2024 | 379 | 1.380 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 10 | 2013 | 83 | 1.310 |
Why?
| Mice, Knockout | 19 | 2023 | 841 | 1.300 |
Why?
| Mice, Inbred C57BL | 23 | 2024 | 1806 | 1.300 |
Why?
| Intercellular Signaling Peptides and Proteins | 16 | 2019 | 104 | 1.190 |
Why?
| Alveolar Bone Loss | 2 | 2024 | 15 | 1.180 |
Why?
| Osteoporosis, Postmenopausal | 4 | 2024 | 32 | 1.140 |
Why?
| Cells, Cultured | 30 | 2018 | 1571 | 1.130 |
Why?
| NF-E2-Related Factor 2 | 2 | 2017 | 41 | 1.100 |
Why?
| Teriparatide | 3 | 2024 | 11 | 1.080 |
Why?
| Diabetes Mellitus, Type 1 | 3 | 2024 | 197 | 1.070 |
Why?
| Focal Adhesion Kinase 2 | 3 | 2019 | 13 | 1.070 |
Why?
| Anoikis | 2 | 2019 | 8 | 0.980 |
Why?
| Diabetes Mellitus, Experimental | 3 | 2024 | 129 | 0.930 |
Why?
| Receptors, Parathyroid Hormone | 3 | 2014 | 9 | 0.910 |
Why?
| Aging | 6 | 2018 | 688 | 0.830 |
Why?
| Mice, Transgenic | 11 | 2015 | 555 | 0.810 |
Why?
| Cell Differentiation | 11 | 2021 | 653 | 0.800 |
Why?
| Parathyroid Hormone-Related Protein | 2 | 2024 | 23 | 0.790 |
Why?
| Bone Marrow | 6 | 2016 | 362 | 0.750 |
Why?
| Cell Survival | 13 | 2019 | 598 | 0.740 |
Why?
| Fractures, Bone | 3 | 2023 | 106 | 0.740 |
Why?
| Calcitriol | 10 | 2005 | 36 | 0.730 |
Why?
| Weight-Bearing | 6 | 2016 | 43 | 0.730 |
Why?
| Female | 43 | 2024 | 26329 | 0.720 |
Why?
| Cell Communication | 3 | 2022 | 69 | 0.700 |
Why?
| Alendronate | 8 | 2015 | 23 | 0.690 |
Why?
| Wnt Proteins | 7 | 2013 | 100 | 0.690 |
Why?
| Mitogen-Activated Protein Kinases | 5 | 2004 | 156 | 0.670 |
Why?
| Stress, Mechanical | 5 | 2013 | 88 | 0.650 |
Why?
| Gap Junctions | 3 | 2017 | 26 | 0.650 |
Why?
| Humans | 63 | 2024 | 49827 | 0.650 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2024 | 467 | 0.630 |
Why?
| Matrix Metalloproteinase 14 | 1 | 2018 | 5 | 0.620 |
Why?
| Interleukin-6 | 10 | 1998 | 264 | 0.610 |
Why?
| Bone Marrow Cells | 9 | 2021 | 192 | 0.580 |
Why?
| Adipogenesis | 1 | 2017 | 51 | 0.570 |
Why?
| Collagen Type I | 4 | 2015 | 89 | 0.570 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2017 | 88 | 0.560 |
Why?
| ortho-Aminobenzoates | 1 | 2016 | 8 | 0.560 |
Why?
| Muscular Atrophy | 1 | 2017 | 70 | 0.550 |
Why?
| Down-Regulation | 7 | 2017 | 349 | 0.550 |
Why?
| Fracture Healing | 1 | 2016 | 27 | 0.550 |
Why?
| Fibroblast Growth Factors | 3 | 2017 | 47 | 0.550 |
Why?
| Adipocytes | 1 | 2017 | 121 | 0.540 |
Why?
| Organ Size | 7 | 2019 | 226 | 0.540 |
Why?
| Peptides | 4 | 2015 | 222 | 0.530 |
Why?
| Cellular Microenvironment | 1 | 2016 | 26 | 0.530 |
Why?
| Models, Biological | 10 | 2016 | 728 | 0.520 |
Why?
| Estrogen Receptor beta | 3 | 2022 | 54 | 0.510 |
Why?
| Caveolin 1 | 2 | 2013 | 21 | 0.510 |
Why?
| src-Family Kinases | 4 | 2005 | 51 | 0.500 |
Why?
| Extracellular Matrix Proteins | 6 | 2022 | 69 | 0.500 |
Why?
| MAP Kinase Signaling System | 4 | 2012 | 118 | 0.490 |
Why?
| Periosteum | 2 | 2012 | 26 | 0.480 |
Why?
| Genetic Markers | 8 | 2020 | 103 | 0.480 |
Why?
| Low Density Lipoprotein Receptor-Related Protein-5 | 4 | 2023 | 7 | 0.470 |
Why?
| Gene Deletion | 7 | 2019 | 266 | 0.470 |
Why?
| Endoplasmic Reticulum | 1 | 2014 | 109 | 0.470 |
Why?
| Hematopoietic Stem Cells | 2 | 2012 | 184 | 0.460 |
Why?
| Periodontitis | 2 | 2024 | 10 | 0.460 |
Why?
| Estrogens | 6 | 2007 | 227 | 0.460 |
Why?
| Phosphorylation | 12 | 2014 | 536 | 0.440 |
Why?
| Cell Line | 16 | 2014 | 1002 | 0.430 |
Why?
| Multiple Myeloma | 5 | 2022 | 2910 | 0.430 |
Why?
| Muscles | 5 | 1993 | 103 | 0.420 |
Why?
| Male | 26 | 2024 | 25093 | 0.420 |
Why?
| Phosphates | 5 | 2016 | 47 | 0.420 |
Why?
| RNA, Messenger | 8 | 2017 | 1105 | 0.410 |
Why?
| Up-Regulation | 7 | 2014 | 450 | 0.400 |
Why?
| Enzyme Inhibitors | 6 | 2014 | 391 | 0.400 |
Why?
| Hyperostosis | 2 | 2022 | 4 | 0.390 |
Why?
| X-Ray Microtomography | 7 | 2023 | 77 | 0.390 |
Why?
| Phosphoproteins | 3 | 2018 | 113 | 0.380 |
Why?
| Gene Expression Regulation | 8 | 2017 | 979 | 0.380 |
Why?
| Disease Models, Animal | 7 | 2024 | 1451 | 0.370 |
Why?
| Gene Expression | 5 | 2017 | 608 | 0.370 |
Why?
| Enzyme Activation | 9 | 2010 | 276 | 0.370 |
Why?
| Estrogen Receptor alpha | 3 | 2022 | 89 | 0.350 |
Why?
| Receptors, Estrogen | 7 | 2022 | 130 | 0.340 |
Why?
| Focal Adhesion Kinase 1 | 2 | 2007 | 15 | 0.340 |
Why?
| MicroRNAs | 3 | 2019 | 354 | 0.330 |
Why?
| Cytokines | 7 | 2014 | 612 | 0.330 |
Why?
| Cell Membrane | 2 | 2007 | 248 | 0.320 |
Why?
| Transcription Factors | 4 | 2023 | 563 | 0.310 |
Why?
| Monocytes | 1 | 2008 | 132 | 0.290 |
Why?
| Periodontal Ligament | 2 | 2024 | 3 | 0.290 |
Why?
| Osteolysis | 3 | 2022 | 75 | 0.280 |
Why?
| Membrane Glycoproteins | 5 | 2003 | 240 | 0.280 |
Why?
| Weightlessness | 1 | 2006 | 14 | 0.270 |
Why?
| Osteoprotegerin | 2 | 2016 | 52 | 0.270 |
Why?
| Protein-Tyrosine Kinases | 3 | 2010 | 95 | 0.270 |
Why?
| Dexamethasone | 7 | 2017 | 429 | 0.270 |
Why?
| Antibodies, Neutralizing | 2 | 2024 | 64 | 0.260 |
Why?
| HeLa Cells | 10 | 2017 | 251 | 0.260 |
Why?
| Calcifediol | 4 | 1991 | 9 | 0.260 |
Why?
| Caspases | 3 | 2006 | 104 | 0.260 |
Why?
| Cell Nucleus | 5 | 2013 | 184 | 0.260 |
Why?
| Integrins | 1 | 2005 | 31 | 0.260 |
Why?
| Skull | 5 | 2015 | 75 | 0.250 |
Why?
| Hormone Replacement Therapy | 1 | 2004 | 27 | 0.240 |
Why?
| Periodontal Diseases | 1 | 2024 | 12 | 0.240 |
Why?
| Caspase 3 | 5 | 2017 | 97 | 0.240 |
Why?
| Estradiol | 9 | 2007 | 225 | 0.230 |
Why?
| Multienzyme Complexes | 1 | 2003 | 35 | 0.230 |
Why?
| Rats | 9 | 2014 | 3300 | 0.230 |
Why?
| Antigens, CD | 4 | 2000 | 215 | 0.230 |
Why?
| Calcium Channels | 2 | 2001 | 46 | 0.230 |
Why?
| Cysteine Endopeptidases | 1 | 2003 | 67 | 0.230 |
Why?
| Gingivitis | 1 | 2023 | 2 | 0.220 |
Why?
| Actins | 2 | 2005 | 118 | 0.220 |
Why?
| Kinetics | 8 | 2004 | 626 | 0.220 |
Why?
| Protein Kinases | 2 | 2014 | 72 | 0.220 |
Why?
| Bone Diseases, Metabolic | 1 | 2023 | 74 | 0.210 |
Why?
| Tumor Necrosis Factor-alpha | 5 | 2016 | 388 | 0.210 |
Why?
| Tuberous Sclerosis | 1 | 2022 | 37 | 0.210 |
Why?
| Tumor Suppressor Proteins | 1 | 2022 | 127 | 0.200 |
Why?
| Absorptiometry, Photon | 3 | 2023 | 154 | 0.200 |
Why?
| Transcription, Genetic | 8 | 2006 | 371 | 0.200 |
Why?
| Transfection | 6 | 2007 | 357 | 0.200 |
Why?
| Phosphotyrosine | 2 | 1999 | 7 | 0.200 |
Why?
| Dihydrotestosterone | 4 | 2006 | 12 | 0.200 |
Why?
| Bone Matrix | 2 | 2019 | 18 | 0.200 |
Why?
| Neoplasm Proteins | 1 | 2003 | 323 | 0.190 |
Why?
| Receptors, Androgen | 3 | 2006 | 46 | 0.190 |
Why?
| Cell Division | 6 | 2005 | 292 | 0.190 |
Why?
| Mutation | 5 | 2023 | 1293 | 0.190 |
Why?
| Calcium | 5 | 2023 | 397 | 0.190 |
Why?
| Trans-Activators | 3 | 2018 | 134 | 0.180 |
Why?
| Ovariectomy | 5 | 2014 | 119 | 0.180 |
Why?
| Phenotype | 3 | 2020 | 727 | 0.180 |
Why?
| Sex Characteristics | 2 | 2023 | 190 | 0.180 |
Why?
| Phylogeny | 1 | 2020 | 230 | 0.180 |
Why?
| Dose-Response Relationship, Drug | 4 | 2021 | 1374 | 0.180 |
Why?
| Dentin | 1 | 2019 | 6 | 0.170 |
Why?
| Cell Proliferation | 2 | 2016 | 1007 | 0.170 |
Why?
| DNA-Binding Proteins | 3 | 2003 | 436 | 0.170 |
Why?
| Calcitonin | 1 | 1999 | 30 | 0.170 |
Why?
| Lymphokines | 2 | 1997 | 20 | 0.170 |
Why?
| Growth Inhibitors | 2 | 1997 | 27 | 0.170 |
Why?
| Protein Binding | 4 | 2011 | 660 | 0.170 |
Why?
| Receptors, Interleukin-17 | 1 | 2018 | 2 | 0.160 |
Why?
| Dental Cementum | 1 | 2018 | 1 | 0.160 |
Why?
| Tooth Ankylosis | 1 | 2018 | 1 | 0.160 |
Why?
| Gonadal Steroid Hormones | 3 | 2007 | 42 | 0.160 |
Why?
| Anabolic Agents | 1 | 2019 | 33 | 0.160 |
Why?
| Bone Diseases | 2 | 2017 | 98 | 0.160 |
Why?
| Tretinoin | 1 | 1999 | 53 | 0.160 |
Why?
| Cyclins | 1 | 1998 | 38 | 0.160 |
Why?
| Mefloquine | 1 | 2018 | 4 | 0.160 |
Why?
| Oxidative Stress | 2 | 2017 | 768 | 0.160 |
Why?
| Primary Cell Culture | 2 | 2017 | 61 | 0.150 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2019 | 595 | 0.150 |
Why?
| Repressor Proteins | 1 | 2019 | 151 | 0.150 |
Why?
| Chick Embryo | 6 | 2001 | 83 | 0.150 |
Why?
| Femur | 2 | 2015 | 133 | 0.150 |
Why?
| Culture Media, Conditioned | 3 | 2023 | 48 | 0.150 |
Why?
| Bone Development | 1 | 2018 | 65 | 0.150 |
Why?
| Nuclear Respiratory Factor 1 | 1 | 2017 | 2 | 0.150 |
Why?
| Basic-Leucine Zipper Transcription Factors | 1 | 2017 | 12 | 0.150 |
Why?
| Glucuronidase | 1 | 2017 | 46 | 0.150 |
Why?
| Mice, 129 Strain | 1 | 2017 | 38 | 0.140 |
Why?
| Osteoporotic Fractures | 1 | 2017 | 11 | 0.140 |
Why?
| Hyponatremia | 1 | 2017 | 11 | 0.140 |
Why?
| Gene Regulatory Networks | 1 | 2018 | 107 | 0.140 |
Why?
| Diet | 1 | 2020 | 564 | 0.140 |
Why?
| Immunohistochemistry | 3 | 2017 | 971 | 0.140 |
Why?
| Infant, Newborn | 1 | 2024 | 2744 | 0.140 |
Why?
| Hypophosphatemia, Familial | 1 | 2016 | 1 | 0.140 |
Why?
| Random Allocation | 1 | 2017 | 280 | 0.140 |
Why?
| Cyclin D1 | 1 | 2016 | 56 | 0.140 |
Why?
| Receptors, Interleukin | 1 | 1996 | 10 | 0.140 |
Why?
| Receptors, Nerve Growth Factor | 1 | 1996 | 6 | 0.140 |
Why?
| Receptors, Cytokine | 1 | 1996 | 11 | 0.140 |
Why?
| Etoposide | 4 | 2005 | 72 | 0.140 |
Why?
| JNK Mitogen-Activated Protein Kinases | 2 | 2007 | 72 | 0.140 |
Why?
| Integrases | 2 | 2022 | 43 | 0.140 |
Why?
| Focal Adhesion Protein-Tyrosine Kinases | 2 | 2010 | 20 | 0.130 |
Why?
| Peptide Fragments | 3 | 2015 | 216 | 0.130 |
Why?
| Time Factors | 7 | 2015 | 2912 | 0.130 |
Why?
| Protein Structure, Tertiary | 4 | 2015 | 253 | 0.130 |
Why?
| Hematopoiesis | 2 | 2014 | 71 | 0.130 |
Why?
| Hindlimb | 1 | 2015 | 30 | 0.130 |
Why?
| Hindlimb Suspension | 1 | 2015 | 37 | 0.130 |
Why?
| Estrenes | 3 | 2006 | 13 | 0.130 |
Why?
| Core Binding Factor Alpha 1 Subunit | 2 | 2006 | 44 | 0.130 |
Why?
| Adiposity | 1 | 2016 | 126 | 0.130 |
Why?
| Promoter Regions, Genetic | 3 | 2008 | 477 | 0.130 |
Why?
| Homeostasis | 2 | 2012 | 199 | 0.130 |
Why?
| Mutation, Missense | 1 | 2015 | 103 | 0.130 |
Why?
| Osteocalcin | 3 | 2014 | 43 | 0.120 |
Why?
| Testosterone | 1 | 1995 | 139 | 0.120 |
Why?
| Enzyme Activators | 1 | 2014 | 8 | 0.120 |
Why?
| Receptors, Calcitriol | 3 | 2005 | 19 | 0.120 |
Why?
| Phosphatidylinositol 3-Kinases | 2 | 2005 | 141 | 0.120 |
Why?
| Protein Kinase C | 2 | 2003 | 71 | 0.120 |
Why?
| Nucleic Acid Synthesis Inhibitors | 2 | 2005 | 15 | 0.120 |
Why?
| Sirtuin 1 | 1 | 2014 | 28 | 0.120 |
Why?
| Organ Culture Techniques | 1 | 2014 | 50 | 0.120 |
Why?
| Protein Tyrosine Phosphatases | 1 | 2014 | 24 | 0.120 |
Why?
| Lymphoid Tissue | 1 | 1994 | 22 | 0.120 |
Why?
| Myeloproliferative Disorders | 1 | 2014 | 27 | 0.120 |
Why?
| LDL-Receptor Related Proteins | 2 | 2011 | 11 | 0.120 |
Why?
| Transcriptome | 1 | 2016 | 313 | 0.120 |
Why?
| Blotting, Western | 5 | 2011 | 602 | 0.110 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2014 | 138 | 0.110 |
Why?
| Transforming Growth Factor beta1 | 1 | 2014 | 59 | 0.110 |
Why?
| Receptors, Steroid | 1 | 1993 | 19 | 0.110 |
Why?
| Injections, Subcutaneous | 1 | 2013 | 52 | 0.110 |
Why?
| Receptor Cross-Talk | 1 | 2013 | 7 | 0.110 |
Why?
| TCF Transcription Factors | 1 | 2013 | 11 | 0.110 |
Why?
| Gene Knockdown Techniques | 1 | 2013 | 106 | 0.110 |
Why?
| Hematologic Neoplasms | 1 | 2014 | 99 | 0.110 |
Why?
| Flavonoids | 1 | 2013 | 58 | 0.110 |
Why?
| Ulna | 2 | 2013 | 13 | 0.100 |
Why?
| RNA, Small Interfering | 1 | 2013 | 215 | 0.100 |
Why?
| Protein Transport | 1 | 2013 | 179 | 0.100 |
Why?
| Flow Cytometry | 2 | 2012 | 470 | 0.100 |
Why?
| Arrestins | 1 | 2011 | 1 | 0.100 |
Why?
| Societies, Scientific | 1 | 2011 | 14 | 0.100 |
Why?
| Immunoenzyme Techniques | 1 | 2012 | 143 | 0.100 |
Why?
| Ligands | 3 | 2007 | 204 | 0.100 |
Why?
| Transgenes | 1 | 2011 | 55 | 0.100 |
Why?
| Health | 1 | 2011 | 25 | 0.100 |
Why?
| Minerals | 1 | 2011 | 32 | 0.100 |
Why?
| Absorption | 1 | 2011 | 22 | 0.100 |
Why?
| Fluorescent Dyes | 2 | 2023 | 101 | 0.100 |
Why?
| Lumbar Vertebrae | 2 | 2018 | 98 | 0.100 |
Why?
| Muscle, Skeletal | 1 | 2017 | 750 | 0.100 |
Why?
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 157 | 0.100 |
Why?
| Etidronic Acid | 2 | 2001 | 4 | 0.090 |
Why?
| Cytokine Receptor gp130 | 4 | 2000 | 12 | 0.090 |
Why?
| Fibroblasts | 3 | 2001 | 343 | 0.090 |
Why?
| Estrogen Antagonists | 2 | 2007 | 21 | 0.090 |
Why?
| Extracellular Matrix | 1 | 2010 | 111 | 0.090 |
Why?
| Spine | 1 | 2010 | 94 | 0.090 |
Why?
| Hormones | 2 | 2008 | 55 | 0.080 |
Why?
| Dactinomycin | 2 | 2003 | 22 | 0.080 |
Why?
| Green Fluorescent Proteins | 3 | 2005 | 90 | 0.080 |
Why?
| Biomedical Research | 1 | 2011 | 231 | 0.080 |
Why?
| Gene Silencing | 1 | 2008 | 121 | 0.080 |
Why?
| Molecular Structure | 2 | 2006 | 297 | 0.080 |
Why?
| Nifedipine | 2 | 2001 | 25 | 0.080 |
Why?
| Base Sequence | 4 | 1998 | 650 | 0.080 |
Why?
| Stem Cells | 2 | 2006 | 171 | 0.080 |
Why?
| Phospholipids | 1 | 1987 | 57 | 0.070 |
Why?
| Cattle | 1 | 2008 | 210 | 0.070 |
Why?
| Tibia | 1 | 2007 | 117 | 0.070 |
Why?
| Dihydroxycholecalciferols | 1 | 1987 | 2 | 0.070 |
Why?
| Genotype | 1 | 2008 | 538 | 0.070 |
Why?
| bcl-Associated Death Protein | 2 | 2003 | 9 | 0.070 |
Why?
| Fatty Acids | 1 | 1987 | 143 | 0.070 |
Why?
| Membrane Proteins | 1 | 1989 | 342 | 0.070 |
Why?
| Leukemia Inhibitory Factor | 2 | 1997 | 13 | 0.070 |
Why?
| Weight Gain | 1 | 2008 | 240 | 0.070 |
Why?
| Spleen | 1 | 2008 | 173 | 0.070 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 2 | 2004 | 51 | 0.070 |
Why?
| Kidney | 1 | 2011 | 665 | 0.070 |
Why?
| Antibodies, Monoclonal | 2 | 2023 | 458 | 0.070 |
Why?
| Disease Progression | 2 | 2021 | 822 | 0.070 |
Why?
| Cell Count | 1 | 2006 | 146 | 0.070 |
Why?
| RNA | 2 | 2005 | 170 | 0.070 |
Why?
| Injections | 1 | 2005 | 55 | 0.060 |
Why?
| Caveolae | 1 | 2005 | 6 | 0.060 |
Why?
| Physical Stimulation | 1 | 2005 | 35 | 0.060 |
Why?
| beta-Cyclodextrins | 1 | 2005 | 16 | 0.060 |
Why?
| Tubulin | 1 | 2005 | 22 | 0.060 |
Why?
| Cell Line, Tumor | 2 | 2021 | 1402 | 0.060 |
Why?
| Cytoskeleton | 1 | 2005 | 39 | 0.060 |
Why?
| src Homology Domains | 2 | 2001 | 8 | 0.060 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 1 | 2005 | 33 | 0.060 |
Why?
| Carrier Proteins | 2 | 2003 | 304 | 0.060 |
Why?
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2004 | 7 | 0.060 |
Why?
| Cycloheximide | 3 | 2005 | 37 | 0.060 |
Why?
| Drug Administration Schedule | 1 | 2005 | 376 | 0.060 |
Why?
| Binding Sites | 3 | 2012 | 377 | 0.060 |
Why?
| Drug Synergism | 1 | 2004 | 150 | 0.060 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 181 | 0.060 |
Why?
| Receptors, Interleukin-6 | 3 | 2000 | 22 | 0.060 |
Why?
| Carcinogens | 1 | 2005 | 199 | 0.060 |
Why?
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2003 | 30 | 0.060 |
Why?
| Nuclear Matrix-Associated Proteins | 1 | 2023 | 2 | 0.060 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 33 | 0.060 |
Why?
| CD40 Ligand | 1 | 2003 | 14 | 0.060 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2023 | 1 | 0.060 |
Why?
| NF-kappa B | 2 | 2014 | 314 | 0.060 |
Why?
| Prednisolone | 2 | 2002 | 55 | 0.060 |
Why?
| DNA | 3 | 2005 | 545 | 0.060 |
Why?
| Alveolar Process | 1 | 2023 | 14 | 0.050 |
Why?
| Models, Genetic | 1 | 2003 | 174 | 0.050 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2003 | 114 | 0.050 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 129 | 0.050 |
Why?
| Homeodomain Proteins | 1 | 2022 | 80 | 0.050 |
Why?
| Tumor Cells, Cultured | 2 | 2002 | 465 | 0.050 |
Why?
| Embryo, Mammalian | 1 | 2001 | 65 | 0.050 |
Why?
| Luminescent Proteins | 1 | 2001 | 53 | 0.050 |
Why?
| Clodronic Acid | 1 | 2021 | 19 | 0.050 |
Why?
| Calcium Channel Blockers | 1 | 2001 | 62 | 0.050 |
Why?
| Models, Animal | 2 | 2013 | 233 | 0.050 |
Why?
| Body Weight | 2 | 2019 | 513 | 0.050 |
Why?
| STAT3 Transcription Factor | 2 | 2000 | 81 | 0.050 |
Why?
| Biotinylation | 1 | 2001 | 26 | 0.050 |
Why?
| Isoquinolines | 1 | 2001 | 25 | 0.050 |
Why?
| Interleukin-5 | 1 | 2000 | 6 | 0.050 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2021 | 210 | 0.050 |
Why?
| Cell-Free System | 1 | 2000 | 13 | 0.050 |
Why?
| Orchiectomy | 2 | 2002 | 41 | 0.050 |
Why?
| Recombinant Proteins | 2 | 1998 | 486 | 0.040 |
Why?
| Odontogenesis | 1 | 2019 | 1 | 0.040 |
Why?
| Dental Pulp | 1 | 2019 | 2 | 0.040 |
Why?
| Odontoblasts | 1 | 2019 | 4 | 0.040 |
Why?
| In Situ Nick-End Labeling | 1 | 1999 | 57 | 0.040 |
Why?
| Semaphorins | 1 | 2019 | 3 | 0.040 |
Why?
| Rifabutin | 1 | 1999 | 5 | 0.040 |
Why?
| Quinones | 1 | 1999 | 8 | 0.040 |
Why?
| Isotretinoin | 1 | 1999 | 6 | 0.040 |
Why?
| Lactams, Macrocyclic | 1 | 1999 | 14 | 0.040 |
Why?
| Benzoquinones | 1 | 1999 | 29 | 0.040 |
Why?
| Transcription Factor AP-1 | 1 | 2019 | 63 | 0.040 |
Why?
| Tooth Eruption | 1 | 2018 | 2 | 0.040 |
Why?
| Sodium | 2 | 1991 | 92 | 0.040 |
Why?
| Biological Transport | 2 | 1991 | 173 | 0.040 |
Why?
| Mice, Mutant Strains | 2 | 2015 | 71 | 0.040 |
Why?
| Cell Adhesion Molecules | 1 | 1999 | 85 | 0.040 |
Why?
| Interleukin-17 | 1 | 2018 | 36 | 0.040 |
Why?
| Cytoplasm | 3 | 2004 | 90 | 0.040 |
Why?
| Inflammation | 1 | 2023 | 604 | 0.040 |
Why?
| Oligonucleotides, Antisense | 1 | 1998 | 28 | 0.040 |
Why?
| Hyperparathyroidism, Primary | 1 | 2018 | 36 | 0.040 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1998 | 67 | 0.040 |
Why?
| Growth Substances | 1 | 1998 | 23 | 0.040 |
Why?
| Molecular Sequence Data | 3 | 1995 | 797 | 0.040 |
Why?
| Connective Tissue Cells | 1 | 1997 | 1 | 0.040 |
Why?
| Ciliary Neurotrophic Factor | 1 | 1997 | 8 | 0.040 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1997 | 34 | 0.040 |
Why?
| Osteogenesis Imperfecta | 1 | 2018 | 38 | 0.040 |
Why?
| Endometrial Neoplasms | 1 | 1999 | 137 | 0.040 |
Why?
| Analysis of Variance | 1 | 1999 | 565 | 0.040 |
Why?
| STAT1 Transcription Factor | 1 | 1997 | 26 | 0.040 |
Why?
| Proto-Oncogene Proteins | 3 | 2005 | 149 | 0.040 |
Why?
| HMGB1 Protein | 1 | 2017 | 17 | 0.040 |
Why?
| Genetic Complementation Test | 1 | 2017 | 48 | 0.040 |
Why?
| Alkaline Phosphatase | 1 | 1997 | 94 | 0.040 |
Why?
| Lymphocyte Activation | 2 | 1995 | 172 | 0.040 |
Why?
| PTEN Phosphohydrolase | 1 | 2017 | 55 | 0.040 |
Why?
| Tumor Suppressor Protein p53 | 1 | 1998 | 202 | 0.040 |
Why?
| Cell Cycle Proteins | 1 | 2018 | 166 | 0.040 |
Why?
| Tetradecanoylphorbol Acetate | 2 | 1994 | 46 | 0.030 |
Why?
| Receptor, Ciliary Neurotrophic Factor | 1 | 1996 | 1 | 0.030 |
Why?
| Receptors, Interleukin-11 | 1 | 1996 | 1 | 0.030 |
Why?
| Interleukin-11 Receptor alpha Subunit | 1 | 1996 | 1 | 0.030 |
Why?
| Receptors, OSM-LIF | 1 | 1996 | 2 | 0.030 |
Why?
| Receptors, Oncostatin M | 1 | 1996 | 2 | 0.030 |
Why?
| Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 1996 | 2 | 0.030 |
Why?
| Gait | 1 | 2017 | 85 | 0.030 |
Why?
| Biological Assay | 1 | 1996 | 45 | 0.030 |
Why?
| Gene Knock-In Techniques | 1 | 2015 | 22 | 0.030 |
Why?
| Nerve Tissue Proteins | 1 | 1997 | 193 | 0.030 |
Why?
| Amino Acid Substitution | 1 | 2015 | 82 | 0.030 |
Why?
| Genetic Loci | 1 | 2015 | 49 | 0.030 |
Why?
| Accidental Falls | 1 | 2017 | 98 | 0.030 |
Why?
| X-Rays | 1 | 2015 | 55 | 0.030 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2015 | 184 | 0.030 |
Why?
| Lymphocytes | 1 | 1995 | 151 | 0.030 |
Why?
| Adenocarcinoma | 1 | 1999 | 401 | 0.030 |
Why?
| Epigenetic Repression | 1 | 2014 | 1 | 0.030 |
Why?
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2014 | 2 | 0.030 |
Why?
| Steroids | 1 | 1995 | 57 | 0.030 |
Why?
| Stem Cell Niche | 1 | 2014 | 9 | 0.030 |
Why?
| Androgens | 2 | 2007 | 69 | 0.030 |
Why?
| Antigens, Differentiation | 1 | 2014 | 17 | 0.030 |
Why?
| Adjuvants, Immunologic | 1 | 1994 | 51 | 0.030 |
Why?
| Inflammation Mediators | 1 | 2014 | 112 | 0.030 |
Why?
| Plasmids | 2 | 2004 | 159 | 0.030 |
Why?
| Bucladesine | 1 | 1993 | 5 | 0.030 |
Why?
| Diglycerides | 1 | 1993 | 9 | 0.030 |
Why?
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 1993 | 9 | 0.030 |
Why?
| Algorithms | 1 | 2017 | 616 | 0.030 |
Why?
| Staurosporine | 1 | 1993 | 12 | 0.030 |
Why?
| Body Composition | 1 | 2015 | 318 | 0.030 |
Why?
| Alkaloids | 1 | 1993 | 32 | 0.030 |
Why?
| Transforming Growth Factor beta | 2 | 2006 | 144 | 0.030 |
Why?
| Haversian System | 1 | 2012 | 1 | 0.030 |
Why?
| Vanadates | 1 | 2012 | 8 | 0.030 |
Why?
| Risk Assessment | 1 | 2017 | 1262 | 0.030 |
Why?
| Heart | 1 | 1994 | 326 | 0.030 |
Why?
| Polymerase Chain Reaction | 1 | 1993 | 455 | 0.030 |
Why?
| Binding, Competitive | 1 | 2012 | 95 | 0.030 |
Why?
| Tissue Distribution | 1 | 2012 | 164 | 0.020 |
Why?
| Immunoprecipitation | 1 | 2011 | 59 | 0.020 |
Why?
| Microscopy, Confocal | 1 | 2011 | 87 | 0.020 |
Why?
| Ion Channels | 1 | 2012 | 72 | 0.020 |
Why?
| Phosphorus Radioisotopes | 1 | 1991 | 8 | 0.020 |
Why?
| Spectrometry, X-Ray Emission | 1 | 2011 | 7 | 0.020 |
Why?
| Cholecalciferol | 1 | 1991 | 23 | 0.020 |
Why?
| Rats, Long-Evans | 1 | 2011 | 26 | 0.020 |
Why?
| Rabbits | 1 | 2012 | 370 | 0.020 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 181 | 0.020 |
Why?
| Microscopy, Electron | 1 | 2011 | 77 | 0.020 |
Why?
| Spectrum Analysis, Raman | 1 | 2011 | 58 | 0.020 |
Why?
| Cell Culture Techniques | 1 | 2011 | 99 | 0.020 |
Why?
| Motor Activity | 1 | 2011 | 230 | 0.020 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 829 | 0.020 |
Why?
| Rats, Sprague-Dawley | 1 | 2014 | 1595 | 0.020 |
Why?
| Physical Exertion | 1 | 2009 | 43 | 0.020 |
Why?
| Leucine | 1 | 1989 | 116 | 0.020 |
Why?
| Antineoplastic Agents | 1 | 2017 | 1172 | 0.020 |
Why?
| Genetic Predisposition to Disease | 1 | 2011 | 510 | 0.020 |
Why?
| Risk Factors | 1 | 2017 | 3619 | 0.020 |
Why?
| In Situ Hybridization | 1 | 2007 | 65 | 0.020 |
Why?
| Rats, Inbred Lew | 1 | 2007 | 69 | 0.020 |
Why?
| Weightlessness Simulation | 1 | 2007 | 19 | 0.020 |
Why?
| 24,25-Dihydroxyvitamin D 3 | 1 | 1987 | 3 | 0.020 |
Why?
| Smad Proteins | 1 | 2006 | 10 | 0.020 |
Why?
| Response Elements | 1 | 2006 | 29 | 0.020 |
Why?
| Bone Morphogenetic Protein 2 | 1 | 2006 | 45 | 0.020 |
Why?
| Vitamin D Deficiency | 1 | 1987 | 44 | 0.020 |
Why?
| Chickens | 1 | 1987 | 106 | 0.020 |
Why?
| Wnt3 Protein | 1 | 2005 | 7 | 0.020 |
Why?
| Wnt1 Protein | 1 | 2005 | 10 | 0.020 |
Why?
| Culture Media, Serum-Free | 1 | 2005 | 15 | 0.020 |
Why?
| Wnt3A Protein | 1 | 2005 | 11 | 0.020 |
Why?
| Culture Media | 1 | 2005 | 93 | 0.020 |
Why?
| MAP Kinase Kinase 4 | 1 | 2005 | 29 | 0.020 |
Why?
| Cholera Toxin | 1 | 2004 | 15 | 0.020 |
Why?
| Active Transport, Cell Nucleus | 1 | 2004 | 34 | 0.020 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 51 | 0.020 |
Why?
| Fatty Acids, Unsaturated | 1 | 2004 | 39 | 0.020 |
Why?
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2003 | 12 | 0.010 |
Why?
| Caspase Inhibitors | 1 | 2003 | 16 | 0.010 |
Why?
| Tensile Strength | 1 | 2003 | 28 | 0.010 |
Why?
| ets-Domain Protein Elk-1 | 1 | 2003 | 5 | 0.010 |
Why?
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2003 | 5 | 0.010 |
Why?
| Phosphotransferases | 1 | 2003 | 16 | 0.010 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2003 | 61 | 0.010 |
Why?
| Selective Estrogen Receptor Modulators | 1 | 2003 | 24 | 0.010 |
Why?
| Proto-Oncogene Proteins c-jun | 1 | 2003 | 75 | 0.010 |
Why?
| Genes, Reporter | 1 | 2003 | 89 | 0.010 |
Why?
| Compressive Strength | 1 | 2002 | 11 | 0.010 |
Why?
| Seminal Vesicles | 1 | 2002 | 13 | 0.010 |
Why?
| Uterus | 1 | 2002 | 94 | 0.010 |
Why?
| Pyrazoles | 1 | 2002 | 113 | 0.010 |
Why?
| Oncostatin M | 1 | 2000 | 5 | 0.010 |
Why?
| 3T3 Cells | 1 | 2000 | 55 | 0.010 |
Why?
| Transcriptional Activation | 1 | 2001 | 122 | 0.010 |
Why?
| Sex Factors | 1 | 2001 | 693 | 0.010 |
Why?
| Stromal Cells | 1 | 1997 | 72 | 0.010 |
Why?
| Proto-Oncogene Proteins c-rel | 1 | 1995 | 5 | 0.010 |
Why?
| Oligodeoxyribonucleotides | 1 | 1995 | 31 | 0.010 |
Why?
| Chloramphenicol O-Acetyltransferase | 1 | 1994 | 8 | 0.010 |
Why?
| Breast Neoplasms | 1 | 2002 | 1169 | 0.010 |
Why?
| Myocardium | 1 | 1994 | 429 | 0.010 |
Why?
| Adult | 1 | 1995 | 13160 | 0.000 |
Why?
|
|
Bellido's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|